Description
Stroke is the leading cause of disability and one of the most common diagnoses in neuro-rehabilitation. Physiatrists and their rehabilitation teams help patients and families as they adjust to new impairments. Motor issues, such as weakness, tone, altered gait, and resulting mobility challenges, are often the most visible stroke sequelae. Non-motor stroke sequelae, including change in cognition, mood, emotions, sleep and fatigue, may be less perceptible but can have an enormous impact on recovery and ongoing function. Impaired cognition, including memory and thinking, can necessitate constant supervision. Alteration in mood and emotions can affect coping, adjustment, and interactions with other people. Changes in sleep and stroke-related fatigue can negatively affect other aspects of function. These varied stroke sequelae and their deleterious effects can be identified and addressed during the course of stroke recovery and rehabilitation. Physiatrists and their teams can help develop and implement individualized plans, involving therapies and medications, with the goal of ameliorating these symptoms and optimizing function and quality of life. This session's faculty will discuss these important issues through didactic overviews, case studies, and an interactive panel discussion.
Learning Objectives
After completing this live activity, the participant should be able to:
- List at least three common non-motor stroke sequelae.
- Discuss methods of identifying and addressing non-motor stroke-related symptoms during stroke recovery and rehabilitation.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Credit Designation
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this live activityfor a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
In accordance with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, AAPM&R requires all individuals who are in a position to affect the strategic direction of AAPM&R and/or control the content of an educational activity to disclose all financial relationships with any ineligible company within the last 24 months. The ACCME defines an “ineligible company” as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Disclosures are made in written form prior to the start of the educational activity, and any potential conflicts of interest that exist are mitigated prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to affect the strategic direction of AAPM&R and/or control content and their disclosed financial relationships are listed below.
No other planners, faculty, or individuals in control of content disclosed any relevant financial relationships.
Principle Faculty
Name, Credential(s): Company Name, Nature of financial relationship;
Diane Mortimer MD, MSN, FAAPMR - Nothing to disclose
Ashley Bedi DO, FAAPMR - Nothing to disclose
Zainab Al lawati MD, FRCPC, FAAPMR - Nothing to disclose
Daniel Krasna MD, FAAPMR - Nothing to disclose
Stacy McCarty MD, FAAPMR - Nothing to disclose
AAPM&R Medical Education Committee
Name, Credential(s): Company Name, Nature of financial relationship
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.